Pharmaceutical Glass Tubing

Pharmaceutical Glass Tubing

Global Pharmaceutical Glass Tubing Market to Reach US$17.9 Billion by 2030

The global market for Pharmaceutical Glass Tubing estimated at US$12.0 Billion in the year 2023, is expected to reach US$17.9 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Glass Tubing for Syringes, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$8.1 Billion by the end of the analysis period. Growth in the Glass Tubing for Ampoules segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 9.6% CAGR

The Pharmaceutical Glass Tubing market in the U.S. is estimated at US$3.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Global Pharmaceutical Glass Tubing Market - Key Trends and Drivers Summarized

Pharmaceutical glass tubing is an essential material used in the packaging and delivery of various pharmaceutical products, primarily injections, vials, ampoules, and syringes. This glass is favored in the pharmaceutical industry due to its inert nature, ensuring that it does not react with the contents it holds, thus maintaining the integrity and efficacy of the medications. There are primarily two types of glass used: Type I borosilicate glass, which has high resistance to thermal and chemical stress, and is suitable for products that are sensitive, acidic, or basic in nature; and Type III soda-lime glass, used for less sensitive products and where more cost-effective solutions are needed. The manufacturing of pharmaceutical glass tubing requires precise control over the material properties to meet rigorous health and safety standards, necessitating advanced production techniques and stringent quality control measures. This glass must be clear or amber in color to protect light-sensitive contents and be able to withstand sterilization processes without degrading.

Innovation in the production of pharmaceutical glass tubing has been significant in responding to the evolving needs of the pharmaceutical industry. Advances in technology have led to the development of more durable glass formulations that enhance the protection of sensitive biologics and vaccines, which are increasingly prevalent in modern healthcare. The introduction of specialized coatings and treatments has also improved the performance of glass containers, making them more resistant to breakage and contamination. Furthermore, environmental considerations are increasingly influencing manufacturing processes, with companies striving to reduce their carbon footprint and improve the sustainability of their products through recycling programs and more efficient manufacturing processes. As biotechnology and personalized medicine continue to advance, the demand for high-quality pharmaceutical glass that can safely store and deliver a wide range of therapies is also rising.

The growth in the pharmaceutical glass tubing market is driven by several factors, including technological advancements in drug manufacturing, increased global pharmaceutical production, and stringent regulatory standards for pharmaceutical packaging. The ongoing shift towards biologics and more complex formulations necessitates the use of high-quality glass that can preserve the stability and sterility of these products. As the global population ages and chronic diseases become more prevalent, there is a corresponding increase in the demand for pharmaceutical products and, by extension, for the high-grade glass needed to package them. The market is also influenced by the tightening of regulations around the world to ensure drug safety and efficacy, which pushes pharmaceutical companies to invest in superior packaging solutions. Additionally, trends in consumer behavior towards more sustainable and safer drug delivery methods encourage further innovations and adaptations in the glass tubing industry. These dynamics, combined with the expansion of healthcare infrastructure in emerging markets, underscore a robust and expanding demand for pharmaceutical glass tubing.

Select Competitors (Total 86 Featured) -

• Accu-Glass LLC
• Cangzhou Four Stars Glass Co., Ltd.
• Corning, Inc.
• DWK Life Sciences GmbH
• Jinan Snail International Co., Ltd.
• Jinan Youlyy Industrial Co., Ltd.
• Nippon Electric Glass Co., Ltd.
• Nipro Europe
• Richland Glass
• Schott AG
• Shandong Linuo Technical Glass Co., Ltd.
• Shandong Pharmaceutical Glass Co., Ltd.
• YuanBo Engineering Co., Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.